Skip to main content
main-content

14-10-2020 | Gastroenterology | Video

UEGW 2020 | Corticosteroids but not TNF-inhibitors increase severe COVID-19 outcomes risk

Ryan Ungaro reports results from the updated SECURE-IBD registry looking at the impact patient characteristics and immunosuppressants have on COVID-19 outcomes in patients with IBD (5:45).

Funding for independent interviews at UEG Week Virtual 2020 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits